Industry reports
Editor highlights

Search inside this page

Publishers

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics in North America Countries, May 2013 (p57)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

1681-1730 of about 7 500 reports
World Pathology: Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2012

World Pathology: Metastatic Hepatocellular Carcinoma (HCC) – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Metastatic Hepatocellular Carcinoma (HCC), complete with latest updates, and special features on late-stage and discontinued projects. It also ...

  • Industries : Pathology
  • Countries : United States, World
Gastric Motility Disorder - Pipeline Review, H2 2013

Gastric Motility Disorder - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Gastric Motility Disorder - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Gastric Motility Disorder - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Therapy
  • Countries : World, United States
Sedation - Pipeline Review, H2 2013

Sedation - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Sedation - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Sedation - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Therapy
  • Countries : World, United States
Iron Deficiency Anemia - Pipeline Review, H2 2013

Iron Deficiency Anemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Iron Deficiency Anemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Iron Deficiency Anemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Pathology
  • Countries : World, United States
Pathology in United States: Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2012

Pathology in United States: Post-Traumatic Stress Disorder (PTSD) – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Post-Traumatic Stress Disorder (PTSD), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews ...

  • Industries : Pathology
  • Countries : United States, World
Pruritus - Pipeline Review, H2 2013

Pruritus - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Pruritus - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Pruritus - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Pathology
  • Countries : Japan, United States, World
Waldenstrom Macroglobulinemia - Pipeline Review, H2 2013

Waldenstrom Macroglobulinemia - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Waldenstrom Macroglobulinemia - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Waldenstrom Macroglobulinemia - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Pathology
  • Countries : United States
World Pathology: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) – Pipeline Review, H1 2012

World Pathology: Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) – Pipeline Review, H1 2012

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

This report provides data on the therapeutic development for Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura), complete with latest updates, and special features on late-stage and ...

  • Industries : Pathology
  • Countries : World, United States
Primary Dysmenorrhea - Pipeline Review, H2 2013

Primary Dysmenorrhea - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Primary Dysmenorrhea - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Primary Dysmenorrhea - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Therapy
  • Countries : World, United States, China
T-Cell Lymphomas - Pipeline Review, H2 2013

T-Cell Lymphomas - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

T-Cell Lymphomas - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'T-Cell Lymphomas - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : United States
Metastatic Ovarian Cancer - Pipeline Review, H2 2013

Metastatic Ovarian Cancer - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Metastatic Ovarian Cancer - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Metastatic Ovarian Cancer - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. ...

  • Industries : Pathology
  • Countries : World, United States
Partial Seizure - Pipeline Review, H2 2013

Partial Seizure - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Partial Seizure - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Partial Seizure - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Drug and Medication
  • Countries : Canada, World, Switzerland
Rabies - Pipeline Review, H2 2013

Rabies - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Rabies - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Rabies - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on ...

  • Industries : Therapy
  • Countries : India, Philippines, World, United States
Hypogonadotropic Hypogonadism - Pipeline Review, H2 2013

Hypogonadotropic Hypogonadism - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Hypogonadotropic Hypogonadism - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Hypogonadotropic Hypogonadism - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Therapy
  • Countries : World, United States
Neuropathy - Pipeline Review, H2 2013

Neuropathy - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Neuropathy - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Neuropathy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Therapy
  • Countries : World, United States
Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2013

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Paroxysmal Nocturnal Hemoglobinuria - Pipeline Review, H2 2013', provides an overview of the indication's ...

  • Industries : Therapy
  • Countries : United States, World
Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2013

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2013', provides an overview of the ...

  • Industries : Pathology
  • Countries : United States
Cardiomyopathy - Pipeline Review, H2 2013

Cardiomyopathy - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Cardiomyopathy - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Cardiomyopathy - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Pathology
  • Countries : World, Canada
Post Menopausal Osteoporosis - Pipeline Review, H2 2013

Post Menopausal Osteoporosis - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Post Menopausal Osteoporosis - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Post Menopausal Osteoporosis - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic ...

  • Industries : Therapy
  • Countries : United States, World
Diphtheria - Pipeline Review, H2 2013

Diphtheria - Pipeline Review, H2 2013

  • $ 2 000
  • Company report
  • October 2013
  • by Global Markets Direct

Diphtheria - Pipeline Review, H2 2013 Summary Global Markets Direct's, 'Diphtheria - Pipeline Review, H2 2013', provides an overview of the indication's therapeutic pipeline. This report provides information ...

  • Industries : Drug and Medication
  • Countries : India, Japan, World, United States
Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report

Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report

  • $ 175
  • Company report
  • October 2013
  • by MarketLine

Rigel Pharmaceuticals, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, ...

  • Industries : Pharmaceutical
  • Countries : United States
BioLineRx, Ltd. (Symbol:BLRX) SWOT Analysis, Strategy, Revenues and Profits

BioLineRx, Ltd. (Symbol:BLRX) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Industry report
  • October 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pharmaceutical
  • Countries : United States
Psychologists, Social Workers & Marriage Counselors Market in the United States

Psychologists, Social Workers & Marriage Counselors Market in the United States

  • $ 1 020
  • Industry report
  • October 2013
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's April Psychologists, Social Workers & Marriage Counselors in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis ...

  • Industries : Health Insurance, Pathology
  • Countries : United States
Mental Health & Substance Abuse Clinics Market in the United States

Mental Health & Substance Abuse Clinics Market in the United States

  • $ 1 020
  • Industry report
  • October 2013
  • by Ibisworld

IBISWORLD INDUSTRY RISK RATINGS REPORT This is the replacement for IBISWorld's November Mental Health & Substance Abuse Clinics in the US Industry Risk Ratings Report. Industry Risk Ratings Synopsis This ...

  • Industries : Pathology
  • Countries : United States
EpiCast Report: Autism Spectrum Disorders - Epidemiology Forecast to 2022

EpiCast Report: Autism Spectrum Disorders - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • October 2013
  • by Global Data

EpiCast Report: Autism Spectrum Disorders - Epidemiology Forecast to 2022 Summary Autism Spectrum Disorders (ASD) is a group of incurable, developmental disabilities which affect the brain and are usually ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany
Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report

Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report

  • $ 175
  • Company report
  • October 2013
  • by MarketLine

Celldex Therapeutics, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, ...

  • Industries : Therapy
  • Countries : United States
Emphysema Global Clinical Trials Review, H2, 2013

Emphysema Global Clinical Trials Review, H2, 2013

  • $ 2 500
  • Industry report
  • October 2013
  • by Global Data

Emphysema Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Emphysema Global Clinical Trials Review, H2, 2013" provides data on the Emphysema clinical trial scenario. ...

  • Industries : Drug Discovery and Development
  • Countries : World, United States
EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022

EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • October 2013
  • by Global Data

EpiCast Report: Gram-Negative Bacterial Pneumonia - Epidemiology Forecast to 2022 Summary Pneumonia is one of the most common infectious diseases and is caused by infectious agents such as bacteria, viruses, ...

  • Industries : Pathology
  • Countries : Japan, United States
Physical Therapy Rehabilitation Centers in the US - Industry Market Research Report

Physical Therapy Rehabilitation Centers in the US - Industry Market Research Report

  • $ 1 020
  • Industry report
  • October 2013
  • by Ibisworld

Physical Therapy Rehabilitation Centers The Physical Therapy Rehabilitation Centers industry left the recession fairly unscathed thanks to industry reliance on Medicare reimbursements. The industry experienced ...

  • Industries : Therapy
  • Countries : United States
World OTC Pharmaceutical Market 2013-2023

World OTC Pharmaceutical Market 2013-2023

  • $ 2 621
  • Industry report
  • October 2013
  • by Visiongain

Report Details Discover the highest potential revenues in over-the-counter medicine What does the future hold for OTC medicines? Visiongain's report shows you potential revenues to 2023, assessing data, ...

  • Industries : Over-the-counter Drug
  • Countries : World, United States

» View Public Reports

About 15 000 reports

Vaccine Market in The United States and Sri Lanka

  • Industry report
  • April 2014
  • 44 pages
  • by Intergovernmental Agency

... Pediatrics 2011 *varicella as the underlying cause of death 1990-1994 to 2004-2007 88% decline overall 67% among 50+ 90% among 20-49 97% among ...


» Read our Company Profiles

About 200 Companies

GlaxoSmithKline P.L.C.

United States

Johnson and Johnson

United States

Biogen Idec

United States

Pfizer Inc.

United States

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.